Keywords: USA, Biotech development, BioSante, AVI BioPharma, Bedford Report, USA

Optimism for US biotech, but developmental drugs draw scrutiny from FDA

Article | 20 July 2011

Print This

There is plenty of optimism surrounding the US biotechnology industry as firmer pricing and new products have improved sales and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in